We have identified a gene, SHR5, in a screen for extragenic suppressors of the hyperactive RAS2 mutation in the budding yeast Saccharomyces cerevisiae. SHR5 was cloned, sequenced, and found to encode a 23-kDa protein not significantly homologous to other proteins in the current data bases. Genetic evidence arguing that Shr5 operates at the level of Ras is presented. We tested whether SHR5, like previously isolated suppressors of hyperactivated RAS2, acts by affecting the membrane attachment and/or posttranslational modification of Ras proteins. We found that less Ras protein is attached to the membrane in shr5 mutants than in wild-type cells and that the Ras proteins are markedly underpalmitoylated, suggesting that Shr5 is involved in palmitoylation of Ras proteins. However, shr5
In the budding yeast Saccharomyces cerevisiae, Ras (31, 44) is regulated positively by the gene product of CDC25 (5, 8) , which encodes its guanine nucleotide exchange factor, and negatively by the gene products of IRA1 and IRA2 (54) , which encode homologs of mammalian GTPase-activating proteins (GAPs). Ras is involved in the regulation of nutrient sensing and mitotic growth through the adenylyl cyclase pathway (4, 58) . Hyperactivation of the Ras-adenylyl cyclase pathway in S. cerevisiae results in several phenotypes, most notably an inability to arrest at G 1 , heat shock sensitivity, nutrient starvation sensitivity, and an inability to sporulate (32, 58) . Although the adenylyl cyclase pathway accounts for much of the Ras effects in S. cerevisiae, there is genetic evidence for an alternate Ras pathway that remains, at present, ill-defined (60) .
In both yeasts and mammals, a progression of modifications of the CAAX motif at the carboxyl terminus of RAS is critical for protein-protein interactions and membrane localization (for reviews, see references 13, 14, 34, 37, 39, and 42) . The initial modification of the CAAX motif is the isoprenylation (farnesylation) of the cysteine (26), which is followed by proteolytic cleavage of the last three amino acids and subsequent carboxy methylation of the terminal polyisoprenylated cysteine (25) . For many Ras proteins (26) , acylation (palmitoylation) of the penultimate cysteine (61) results in the fully matured form of the protein. Whereas farnesylation of mammalian Ras has been shown to be critical for its function (11, 33) , the role of palmitoylation appears to be limited to the efficient attachment of Ras proteins to membranes (26) . Similarly, farnesylation of yeast Ras2 protein significantly increases its ability to activate and associate with adenylyl cyclase, whereas palmitoylation promotes its effective membrane localization (35) and its specific targeting to the plasma membrane (43) .
Elements involved in the effector function, regulation, and modification of Ras proteins have previously been identified in this and other laboratories by selection for mutants that suppress RAS2
Val-19 function in S. cerevisiae. Suppressor mutations in CYR1, which encodes adenylyl cyclase (30) , and CAP, which encodes a protein that binds to adenylyl cyclase (16) , were isolated. Suppressors of RAS2
Val-19 also led to the initial identification of genes involved in Ras protein modification, RAM1 and RAM2, that encode the subunits of the heterodimeric Ras farnesyltransferase (19, 22, 27, 45, 52) . Here, we present genetic and biochemical characterization of another gene that we identified from analysis of phenotypic revertants of a RAS2 mutant. We designate this gene SHR5 (suppressor of hyperactive RAS2 ), since it represents the fifth gene identified as an extragenic suppressor of RAS2 .
MATERIALS AND METHODS
Yeast strains and plasmids. The yeast strains and plasmids used in this study are described in Table 1 . Various strains were disrupted with plasmid p⌬F-H3 or p⌬F-L2 as described below. BCY1 in strain SP⌬FB was disrupted with plasmid pbcy1::URA3 (56) . Construction of SHR5 plasmids is described below.
Isolation of extragenic suppressors of RAS2 .
S. cerevisiae strains carrying an activated RAS2
Val-19 allele do not become heat shock resistant upon reaching stationary phase (50) . We exploited this phenotypic difference to isolate revertants of the ras1 null RAS2 Val-19 strain PT1-6. A genetic screen previously used for isolation of the ram1 and ram2 mutants (27, 45) was modified as follows. Individual colonies were incubated in liquid medium at saturation at 30ЊC for 4 days and then heat shocked for 30 min at 50ЊC in glass tubes. The heat-shocked cultures were then plated, and surviving colonies were isolated and retested for heat shock resistance by a plate assay (50) .
Isolation of SHR5 and genetic manipulations. RAS2 -containing strains are more heat shock resistant when they reach stationary phase if they contain an shr5 allele. Therefore, the gene for SHR5 was isolated by selection for reversal of the heat shock resistance in the RAS2 shr5 strain RS44-5B. Briefly, these cells were transformed with an S. cerevisiae genomic DNA library constructed in the centromeric vector YCp50 (libraries AB493, AB494, AB495, and AB496 [kindly provided by Mark Rose]), and approximately 200 transformants per plate were grown on selective medium. One week later, 15,000 colonies were replicated onto plates previously equilibrated to 55ЊC for heat shocks of 5-and 10-min durations. Transformants that recovered their sensitivity to heat shock were isolated. Plasmid DNA was isolated from these cells and tested for its ability to rescue heat shock sensitivity when it was retransformed into strain RS44-5B. Plasmids that rescued shr5 were mapped by restriction analysis and subcloned into the yeast plasmid pRS416 (53) . The ability of subclones to rescue shr5 allowed localization of the gene to a 1.8-kb fragment which was sequenced bidirectionally by the Sanger method ( Fig. 1) (49) . The open reading frame (ORF) encoding SHR5 was amplified by PCR using the oligonucleotide pair 5Ј-TACTCAATCTAACCCGTCGACGATGTGC-3Ј and 5Ј-CACGATAAAGC CCTGGTCGACCCATAAA-3Ј, which contain internal SalI sites (in boldface), to facilitate cloning into identical sites in the S. cerevisiae expression plasmids pAD4⌬ (2) and pAD54 (15) , creating plasmids pAD4⌬-SHR5 and pAD54-SHR5, respectively.
Plasmids designed for a one-step gene disruption (47) of SHR5 were constructed that contained deletions from the XbaI site to the BsaBI site in the ORF of SHR5, with insertions of a 1.8-kb HIS3 fragment (28), creating plasmid p⌬F-H3, or of a 2-kb LEU2 fragment (28), creating plasmid p⌬F-L2. This effectively deleted all but the first four amino acids of Shr5. SHR5 was disrupted by transformation of various yeast strains with a SalI-EcoRI fragment derived from p⌬F-H3 or a SphI-SacI fragment derived from p⌬F-L2. Successful disruptions were confirmed by PCR using an oligonucleotide primer pair that flanked the deletion.
Integrative mapping was performed by mating SP⌬F␣ (MAT␣ shr5::HIS3) and strain SN12 (MATa shr5) transformed with plasmid YEp13-PDE2.2 (50) . Highlevel expression of a yeast phosphodiesterase gene allows sporulation in diploids that express hyperactive RAS2 (58) . Heat shock and temperature sensitivity assays. Heat shock assays (50, 58) were performed by replica plating patches of cells that had been starved for 2 to 3 days onto plates that were preheated for 1 h at 55ЊC and then by incubation for 2.5, 5, and 10 min at the same temperature and transfer to 30ЊC for 2 to 3 days. Temperature sensitivity assays were performed by replica plating patches of cells onto plates that were then incubated at the temperatures indicated in the respective figures. (15, 23, 62) proteins, were grown in synthetic medium with galactose to late log phase. The cells were pelleted and washed with ice-cold buffer E (0.3 M sorbitol, 0.1 M NaCl, 5 mM MgCl 2 , 10 mM Tris [pH 7.4]), resuspended in 500 l of buffer E containing 1 mM phenylmethylsulfonyl fluoride and 1 g of aprotinin per ml, and lysed with glass beads and vortexing. The lysate was cleared by centrifugation at 500 ϫ g for 10 min to obtain the supernatant and pellet fractions. Fifteen microliters of each fraction was mixed with 15 l of 2ϫ Laemmli loading buffer (36), subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to nitrocellulose paper. Immunoblotting with 12CA5 antibody (41) was performed as described elsewhere (15) and visualized with enhanced chemiluminescence reagents (Amersham, Arlington Heights, Ill.).
In vitro palmitoylation assay. In vitro acylation (palmitoylation) assays were performed essentially as described by Gutierrez and Magee (24) H(N)] palmitic acid; 47 Ci/mmol; DuPont-New England Nuclear, Boston, Mass.}, and 5 g of yeast extract in a total volume of 100 l. Incubations were carried out for 1 h at 37ЊC and stopped by the addition of 500 l of cold acetone. Acetone precipitates were resuspended in Laemmli loading buffer (36) containing 100 mM dithiothreitol and were subjected to electrophoresis in SDS-12% PAGE. The gels were treated with ENTENSIFY (DuPont-New England Nuclear) according to the directions supplied by the manufacturer and were exposed directly to Kodak XAR-5 film at Ϫ85ЊC.
RESULTS

Identification of shr5 as an extragenic suppressor of RAS2
Val-19 and cloning of the wild-type SHR5 gene. RAS2 mutants, unlike wild-type yeast cells, are not heat shock resistant upon reaching stationary phase (50) . We exploited this phenotypic difference to isolate revertants from the ras1 null
RAS2
Val-19 mutant strain PT1-6 (45). Sixty-four independently derived revertants were obtained in a heat shock screen as described in Materials and Methods. On the basis of complementation analysis, 55 of 64 of these revertants were due to either recessive mutations in the adenylyl cyclase gene or intragenic suppressor mutations in the RAS2
Val-19 gene itself. Three of the remaining nine revertants formed a single complementation group, supF, that we now call shr5. In plate assays, RAS2
Val-19 shr5 revertants were not as heat shock resistant as wild-type cells and, unlike wild-type cells, had low levels of glycogen (29) . By these criteria and in contrast to ram1 (45) , ram2 (45), or cyr1 (30) suppressor mutations, shr5 is only a partial suppressor of RAS2 . The SHR5 gene was isolated by screening a centromeric genomic DNA library for plasmids that reversed the heat shock resistance of RAS2 shr5 cells. One of 15,000 transformants that reversed heat shock resistance in a plasmid-dependent manner was isolated. Plasmid pSHR5-19.7 was recovered from the revertant and contained a 19-kbp insert. Deletion analysis led to the subcloning of a 1.8-kb MscI-ClaI fragment that could rescue shr5. The fragment was completely sequenced (Fig. 1) , and a 765-bp ORF was identified. In-frame stop codons were found upstream of the first ATG. The ORF can encode a product of about 26.7 kDa (see below). Comparison with available databases failed to identify significant homology to other proteins.
Several genetic criteria indicating that the isolated gene was indeed SHR5 were satisfied. First, plasmids were constructed for the disruption of SHR5. Disruption of SHR5 in a RAS2
Val-19 strain resulted in heat shock-resistant cells (Fig. 2 , rows 3 and 4). Disruption of SHR5 in a wild-type strain had no effects on its heat shock sensitivity (Fig. 2, rows 1 and 2) . Second, we found that expression of the predicted ORF from FIG. 2. Reversal of heat shock sensitivity by SHR5 disruption and reconstitution of heat shock sensitivity by expression of the SHR5 cDNA. The SHR5 strain is wild-type SP1 (row 1); the shr5 Ϫ strain is SP⌬F (row 2); the RAS2 strain is TK161-R2V (row 3); the RAS2 Val-19 shr5 null strain is TK⌬F (rows 4 and 5). The rescue of the shr5 disruption in strain TK⌬F (row 4) was with plasmid pAD54-SHR5, expressing a cDNA for SHR5 (row 5). Cells were heat shocked at 55ЊC for 10 min (10Ј). cdc25 null strain also attenuated its heat shock sensitivity. We then determined if an SHR5 disruption can attenuate the heat shock sensitivity created by hyperactivation of downstream elements in the Ras-adenylyl cyclase pathway. BCY1 (56) encodes the regulatory component of the protein kinase A subunits encoded by the TPK genes (57), and its disruption results in hyperactivation of the kinases leading to heat shock sensitivity. A bcy1 null shr5 null strain remained heat shock sensitive in the presence or absence of SHR5. Disruption of SHR5 also failed to attenuate the heat shock sensitivity of wild-type strains overexpressing either protein kinase A (TPK1) or adenylyl cyclase (CYR1). Therefore, disruption of SHR5 blocks Ras function but fails to block elements downstream of Ras.
shr5 attenuates hyperactive RAS2 Val-19 in the absence of the effector adenylyl cyclase. The severe growth defect resulting from disruption of adenylyl cyclase in S. cerevisiae T158-5A1 can be rescued by overexpression of SCH9, a gene encoding a protein kinase with homology to the TPK-encoded protein kinases (55) . For convenience, we refer to this strain as cyr1 null SCH91. We tested the consequence of overexpressing activated RAS2 in this strain and found that it leads not to heat shock sensitivity but to a severe growth defect (Fig. 3,  sector 1 ) and a starvation sensitivity (29) . Since adenylyl cyclase is absent from this strain, it is unlikely that the RAS2 -dependent effects are mediated through the cyclic AMP (cAMP) pathway. The growth defect resulting from overexpression of RAS2 in a cyr1 null SCH91 strain was suppressed by disruption of SHR5 (Fig. 3, sectors 1 and 2 ), whereas expression of SHR5 by itself had no effect on cell growth (Fig. 3, sectors 3 and 4). The growth defect was also suppressed by overexpression of the GAP encoded by NF1 (1), therefore indicating that the effect is through Ras (29) . This result is consistent with previous observations that NF1 can inhibit the function of activated H-ras (1). We observed similar results for starvation sensitivity, which can also be attenuated by disruption of SHR5 or by overexpression of the NF1 gene (29) . These experiments indicate that shr5 can attenuate Ras function in the absence of adenylyl cyclase.
shr5 affects the growth-promoting function of normal Ras. We had established that disruption of SHR5 suppresses hyperactive RAS2 , but could not find any phenotypic effects of disrupting SHR5 in a wild-type background, suggesting that SHR5 does not play a role in the normal growth-promoting function of Ras. To address this issue more critically, we needed to test whether SHR5 played a role in promoting growth when Ras was weakened mutationally. Whereas hyperactivation of Ras leads to heat shock sensitivity (50, 58) , loss of Ras function manifests as a temperature sensitivity (57, 60 ). Therefore, we tested whether disruption of SHR5 had any effects in a ras1 null or a ras2 null background, using a temperature sensitivity assay (Fig. 4) . Disruption of SHR5 in a ras1 null RAS2 background did not lead to any discernible phenotype. In contrast, disruption of SHR5 significantly amplified the mild
FIG. 3. SHR5 attenuates RAS2
Val-19 in the absence of the effector adenylyl cyclase. The cyr1 Ϫ strain, whose viability was rescued by overexpression of SCH9, was transformed with the indicated plasmids. RAS2 was expressed from the LEU2-based plasmid YEp112-RAS2 . SHR5 was expressed from the TRP1-based plasmid YCp22-SHR5. Transformants were streaked onto plates, and the plates incubated at room temperature. 
a Dependence of heat shock sensitivities on SHR5. All strains used contained disruptions of the SHR5 gene. These strains were transformed with plasmid YCp22-SHR5 for expression of SHR5 (ϩSHR5) or the parental plasmid YCplac22 as a control (ϪSHR5). Heat shocks were performed as described in the text. ϩ and Ϫ, maintenance or attenuation of heat shock sensitivity, respectively; 1, overexpression of the gene TPK1 or CYR1 from plasmid YEp13-TPK1 or YEp13-CYR1, respectively. temperature-sensitive growth defect of ras2 null mutants, such that the double shr5 null ras2 null mutants did not grow at 36ЊC (Fig. 4, row 4 ). This result was confirmed in analysis of a cross between an shr5 null mutant and a ras2 null mutant. In 10 complete tetrads, only the eight double ras2 null shr5 null mutants were temperature sensitive at 36ЊC. Thus, Ras1 protein is unable to promote growth at 36ЊC when SHR5 is absent.
To test whether SHR5 affected the growth-promoting function of a mutationally weakened Ras2 protein, we also disrupted SHR5 in the STS1 strain carrying a RAS2 allele with a mutation in the effector region (10, 46) . This strain, which is also ras1 null , cannot grow at 37ЊC but retains the ability to grow at 34ЊC. Disruption of SHR5 in this strain blocks the ability to grow at 34ЊC. This effect of the combined mutations was confirmed by tetrad analysis (29) . SHR5 can, therefore, influence the growth-promoting function of both Ras1 and Ras2 proteins.
We next showed that loss of SHR5 function results in attenuation of the Ras-adenylyl cyclase pathway. Elements in this pathway were tested to determine if they alter the increased temperature sensitivity of the RAS1 ras2 null shr5 null strain. We found that such cells transformed with a control plasmid or a CDC25 expression plasmid remained temperature sensitive at 37ЊC, whereas expression of RAS2, SHR5, or CYR1 was able to reverse the temperature sensitivity (Fig. 5) .
shr5 mutants are defective in the membrane attachment and palmitoylation of RAS2 proteins. The epistasis results suggested that SHR5 might operate at the same level as Ras. Therefore, we sought to determine whether the posttranslational modification or membrane attachment of Ras proteins was altered in shr5 mutants. We analyzed the membrane attachment of Ras proteins by biochemical fractionation and immunoblotting with anti-Ras antibodies (Fig. 6A) . A significant proportion of Ras2 proteins in Shr5 mutants is found in the soluble fraction. This contrasts with the undetectable Ras2 protein from the soluble fraction in wild-type cells and the much more severe mislocalization to the soluble fraction seen in ram1 mutants. This partial mislocalization of Ras2 proteins to the soluble fraction in Shr5 mutants was observed in repeated experiments.
We sought to determine whether the mislocalized protein was processed in shr5 mutants. The Ras2 protein in shr5 mutants is likely to be polyisoprenylated, since in other experiments it clearly comigrated with fully processed Ras2 from wild-type cells and did not comigrate with unprocessed Ras2 from ram1 mutants (29) . (This difference is not evident in the experiment depicted in Fig. 6 , in which the proteins were separated on a minigel of insufficient resolving capacity.) Then, we decided to examine whether the mislocalization of Ras2 protein in shr5 mutants might be due to a defect in palmitoylation of Ras2 protein. It has been established that the efficient attachment and specific targeting to plasma membranes for mammalian H-ras is dependent on this final processing step, and similar results have been obtained for yeast Ras2 protein (43) . Therefore, we performed metabolic labeling with [ 3 H] palmitic acid and immunoprecipitated Ras2 proteins for analysis by SDS-PAGE and autoradiography. As seen in Fig. 6B , there is a significant defect in the palmitoylation of Ras2 protein in shr5 mutants. The metabolically labeled extracts were immunoblotted for the detection of Ras2 protein to show that the amount of Ras2 protein did not differ substantially between the wild-type and shr5 mutants (Fig. 6C) . Results from Fig. 6B and C are quantitated in Table 3 .
We conclude from this series of experiments that Ras2 protein is mislocalized in shr5 mutants and has diminished palmitoylation.
Evidence that Shr5 is membrane associated and is not the Ras protein palmitoyltransferase. We examined the subcellular localization of HA1 epitope-tagged Shr5 protein by bio -FIG. 4 . Increased temperature sensitivity of shr5 null strains. The ras1 Ϫ RAS2 SHR5 strain is ST-1 (row 1). The ras1 Ϫ RAS2 shr5 Ϫ strain is ST⌬F (row 2). The RAS1 ras2
Ϫ SHR5 strain is KP-2 (row 3). The RAS1 ras2 Ϫ shr5 Ϫ strain is KP⌬F (row 4). Temperature sensitivity assays were carried out as described in the text. Triplicate plates were incubated at room temperature (A), at 36ЊC (B), or at 38ЊC (C).
FIG. 5. Reversal of temperature sensitivity of RAS1 ras2
Ϫ shr5 Ϫ strain RS81-1B by elements of the RAS-adenylyl cyclase pathway. The indicated strains were transformed with plasmids expressing various indicated genes (see Table 1 ) (A). Transformed cells were streaked onto duplicate plates and then incubated at 30ЊC (B) and 37ЊC (C). migrates significantly more slowly than predicted from its mass (Ϸ28.7 kDa). Recombinant Shr5 expressed in bacteria also migrates slowly (29) .
To determine if shr5 mutants are defective for Ras protein palmitoyltransferase activity, we performed an in vitro assay for palmitoylation of Ras proteins according to the procedure developed by Magee and coworkers (38) . Whole-cell extracts were prepared from strains which overexpressed Ras2 protein and were incubated with [ 3 H]palmitate in the presence of cofactors to promote in vitro palmitoylation of proteins. As shown in Fig. 7B , shr5 mutants display as many palmitoylated protein bands as do wild-type cells. In fact, for the shr5 mutant, there is increased labeling of a band that migrates at the molecular mass predicted for Ras2, 42 kDa, and that is only present in experiments performed with strains overexpressing Ras2 protein. This effect of increased labeling of the 42-kDa protein in shr5 mutants is more pronounced with shorter incubation times and with lower amounts of added extract (29) . This result indicates that in shr5 mutants, there is a larger pool of nonpalmitoylated Ras2 protein available for palmitoylation in the in vitro assay. This is consistent with our findings of a defect in palmitoylation of Ras2 protein by metabolic labeling. There is certainly no evidence for a defect in protein palmitoylation by this in vitro assay.
Evidence that Shr5 interacts in vivo with nonpalmitoylated and with completely unprocessed Ras2 proteins. The results from the previous section suggested that SHR5 does not encode the Ras palmitoyltransferase. To test whether the major phenotypic effect of SHR5 is mediated by its effects on Ras2 palmitoylation, we asked whether SHR5 could interact genetically with RAS2 alleles missing the unique cysteine palmitoylation site at position 318 (6, 27, 44) . Indeed, we found by a temperature sensitivity assay that the absence of SHR5 blocked the growth of RAS2 Ser-318 strains at 38ЊC (Fig. 8 ). This effect is specific to the Ras-adenylyl cyclase pathway since it can be suppressed by overexpression of protein kinase A. We showed similar results for the hyperactivated RAS2
Val-19Ser-318 allele which, although attenuated, is still capable of producing a significant heat shock-sensitive phenotype (44) . We found that the shr5 null mutation suppressed the heat shock sensitivity induced by this nonpalmitoylatable version of hyperactive RAS2 (29) . Thus, the ability of the shr5 deletion to suppress hyperactive RAS2 does not depend on its palmitoylation status.
We decided to take this analysis one step further and ask if the ability of SHR5 to influence Ras function required that Ras proteins be farnesylated. RAS2 alleles encoding a serine instead of a cysteine at position 319 within the CAAX box are blocked for farnesylation but can supply essential function if they are overexpressed (12) . We have found that the nonfarnesylated RAS2
Val-19Phe-319 allele can promote growth at room temperature and weakly at higher temperatures (10) . To test if SHR5 influenced the ability of nonfarnesylated Ras2 protein to promote growth in this background, we deleted SHR5 in a ras1
null RAS2 Val-19Phe-319 strain and examined its growth properties (Fig. 8) . Deletion of SHR5 blocks the ability of the strain to grow at 34ЊC. This effect is specific to the Ras-adenylyl cyclase pathways, since it can be reversed by overexpression of protein kinase A. The synergistic temperature-dependent growth defect was also confirmed by analysis of a cross between a shr5 strain and a ras1 null RAS2 strain (29) . The ability of Shr5 to influence the function of Ras does not appear to depend on its modification status. We then showed by a novel assay that SHR5 disruptants exhibit attenuated Ras pathway function even in the absence of adenylyl cyclase. This assay was based on the observation that overexpression of RAS2
DISCUSSION
Val-19 conferred a phenotype in a cyr1 null strain whose viability had been rescued by overexpression of a downstream kinase encoded by SCH9 (55) . cyr1 null
SCH91 RAS2
Val- 19 1 cells are not heat shock sensitive but are growth inhibited and starvation sensitive. The observation of a RAS2 -dependent phenotype in a cyr1 null strain supports the alternate-Ras pathway hypothesis that was originally proposed to explain the lethality of a ras null strain versus the viable but sick cyr1 null strain (60) . Disruption of SHR5 attenuated the RAS2 phenotype in this strain, indicating that Shr5 functions at the level of Ras and not on adenylyl cyclase or its downstream targets.
We investigated the possibility that Shr5 is involved in Ras modification, since previously isolated suppressors of RAS2 had defects in genes encoding the subunits of Ras farnesyltransferase, ram1 and ram2. Indeed, fractionation studies indicate that shr5 mutants are partially defective in Ras localization; a larger portion of Ras in shr5 mutants is cytosolic than in wild-type cells, in which Ras is predominantly localized to the membrane. In addition, there is a defect in the palmitoylation of Ras protein in shr5 mutants. The comigration of Ras protein from shr5 mutants with the proteolytically processed Ras protein from wild-type cells makes it unlikely that shr5 mutants are defective in farnesylation, since mutants defective in farnesylation display altered migration of Ras proteins on SDS-PAGE.
The defect in palmitoylation of Ras suggests that SHR5 encodes a component of a Ras palmitoyltransferase. Therefore, we tested if extracts prepared from shr5 mutants are defective for palmitoylation of endogenous proteins, including Ras. By a cell-free assay, no palmitoylation defect was observed in shr5 mutants. In fact, in such cells we observed increased labeling of a band that coincides with Ras2, perhaps because, as we demonstrated, shr5 mutants have an increased amount of unpalmitoylated Ras that can serve as a substrate Comparison of in vitro palmitoylation of proteins in extracts prepared from wild-type (wt) and shr5 mutant cells. Extracts were prepared from wild-type strain SP1 and shr5 mutant strain SP⌬F; both were transformed by the highcopy-number plasmid expressing Ras2 and assayed according to the method described by Magee et al. (38) To date, the data suggest but do not prove that Shr5 is specific for Ras. First, in the comparison of shr5 mutants and wild-type cells, the in vitro palmitoylation defect appeared to be specific only for Ras but not other protein bands (Fig. 7B) , even though similar levels of Ras protein were expressed (Fig.  6C ). However, it is possible that Shr5 modifies the palmitoylation of other proteins that are expressed at levels too low to detect in this assay. Second, there are other G proteins in S. cerevisiae that might be affected by Shr5 function: Rsr1 (Bud1) (9, 48) , which is involved in budding, and Ste18 (18, 59) , which is involved in mating. We found that shr5 null mutants are neither budding nor mating defective (29) , suggesting that the absence of Shr5 did not attenuate the activities of these other G proteins. It remains possible that Shr5 has wider functions, even though there are no apparent differences between shr5 null and wild-type cells. The role of SHR5 becomes manifest only under synthetic conditions, such as in our case, when mutant forms of RAS are being used. It is possible that other roles for Shr5 can be discerned under other synthetic conditions. Although the evidence indicates that Shr5 might be specific for Ras, more confirmatory work is necessary.
What might be the function of Shr5? Although more complex models are possible, the most compelling indication of Shr5 function is suggested by its ability to influence localization and palmitoylation of Ras. Our data are consistent with a model in which Shr5 promotes attachment to the membrane and the defect in palmitoylation is a secondary consequence of this defect in membrane attachment. This is consistent with our observation of no defect in palmitoyltransferase activity per se. The ability of Shr5 to influence completely unmodified Ras proteins suggests that even for the function of nonmodified Ras, at least some proper localization to the membrane is important, and this is supported by the recent report of Deschenes and coworkers (40) . Membrane localization might be important if the interaction of Ras with either active Cdc25 protein or effector took place exclusively in the membranes. The ability of Shr5 to functionally interact with unprocessed Ras and to influence Ras localization to the membrane suggests that it might be involved in the plasma membrane targeting of Ras proteins (7, 51) and that its function is not solely dependent on recognition of the lipid groups. Thus far, we have not detected interaction of Shr5 with Ras by the two-hyrid method (17) , thus suggesting that Shr5 functions as an element in a protein complex, that its effects on Ras is indirect, or that its interaction is too transient to observe. The isolation of proteins that function in concert with or that directly interact with Shr5 should further our understanding of how Ras localization is controlled and how this might impact Ras function.
